Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
DYAX > SEC Filings for DYAX > Form 8-K on 29-Dec-2011All Recent SEC Filings

Show all filings for DYAX CORP

Form 8-K for DYAX CORP


29-Dec-2011

Other Events


Item 8.01. Other Events.

On December 26, 2011 Dyax Corp. ("Dyax") and Defiante Farmaceutica S.A., an affiliate of the pharmaceutical group Sigma-Tau ("Sigma-Tau"), entered into a Third Amendment (the "Third Amendment") to the Joint Development and License Agreement dated effective as of June 18, 2010, as amended by the First Amendment to Joint Development and License Agreement dated December 21, 2010 and the Second Amendment to Joint Development and License Agreement dated May 21, 2011.

The Third Amendment eliminates Sigma-Tau's rights to develop and commercialize KALBITOR (ecallantide) in Taiwan, Singapore and South Korea. This reduction in territories removes Sigma-Tau's obligations to pay milestones, development costs or other compensation or reimbursement in relation to Taiwan, Singapore and South Korea. As a result, Sigma Tau's obligation to make an upfront payment of $3 million, which was payable to Dyax under the existing agreement on or before December 31, 2011, as well as downstream milestone and royalty payments related to the eliminated territories, has been terminated.

All other terms with respect to the rights and obligations under the agreements between Dyax and Sigma Tau remain unchanged.


  Add DYAX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for DYAX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.